Cerebral Amyloid Angiopathy: Clinical Trials

38 trials for Cerebral Amyloid Angiopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 9 unknown, 7 recruiting, 3 active not recruiting. 8 Phase 2, 7 Not applicable, 4 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Active not recruiting 2, Completed 2, Recruiting 2, Enrolling by invitation 1, Unknown 1
Not applicable7Completed 3, Unknown 2, Recruiting 1, Withdrawn 1
Phase 34Unknown 2, Completed 1, Recruiting 1
Phase 11Unknown 1

Follow Cerebral Amyloid Angiopathy: new trials by email Literature Review of Cerebral Amyloid Angiopathy trials Research Report on Cerebral Amyloid Angiopathy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)
AI, healthy dialogue - Stroke, Moyamoya Disease
Not applicableRecruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta202026-10-012026-08-28
Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy
Jiedu Huayu Oral Prescription, Placebo - Cerebral Amyloid Angiopathy
Phase 3RecruitingBeijing Tiantan Hospital4362026-01-302026-09-30
Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage
Colchicine 0.5mg, Matching placebo - Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar
Phase 2RecruitingHuashan Hospital802025-06-182025-06-26
Dilated Perivascular Spaces in the Dentate Nucleus on MRI in Patients With Hypertensive Angiopathy or Cerebral Amyloid Angiopathy
Hypertensive Arteriopathy, Cerebral Amyloid Angiopathy
CompletedCentre Hospitalier Universitaire de Nīmes722025-04-012026-05-29
Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy
XYWAV, gammaCore Sapphire - Cerebral Amyloid Angiopathy
Phase 2Enrolling by invitationLeiden University Medical Center602025-03-272026-02-24
ApoE Genotyping Analysis in Patients With Suspected Non-haemorrhagic Amyloid Angiopathy
Amyloid Angiopathy
CompletedCentre Hospitalier Universitaire de Nīmes1002025-02-012026-06-18
Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.
Mediterranean Diet with Extra Virgin Olive Oil, Mediterranean Diet with Walnuts, Low-Fat Control Diet - Cerebral Amyloid Angiopathy, CAA - Cerebral Amyloid Angiopathy
RecruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta862024-10-102026-09-01
A Study of AMDX-2011P in Participants With CAA
AMDX-2011P - Cerebral Amyloid Angiopathy
Phase 2RecruitingAmydis Inc.252024-07-092026-02-13
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
Placebo, ALN-APP - Cerebral Amyloid Angiopathy
Phase 2Active not recruitingAlnylam Pharmaceuticals2102024-05-172026-10-20
Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA)
NACA - Hereditary Cystatin C Amyloid Angiopathy (HCCAA), Hemorrhage Brain
Phase 2Active not recruitingArctic Therapeutics152024-04-032026-07-21
Brain Hemorrhage and Functional Outcome in Stroke Patients With CAA Features on Pre-thrombolysis MRI Treated With Intravenous Thrombolysis (Thrombolysis in CAA) ( Thromb in CAA )
None, pure observational study - Hemorrhage, Cerebral Amyloid Angiopathy
CompletedCentre Hospitalier Universitaire de Nīmes152022-10-022025-12-10
Periventricular White Matter Hyperintensities in Cerebral Amyloid Angiopathy and Hypertensive Arteriopathy
None, pure observational study - Cerebral Amyloid Angiopathy, Hypertensive Arteriopathy
CompletedCentre Hospitalier Universitaire de Nīmes3152022-09-052025-12-04
MRI-markers to Monitor Small Vessel Disease Dynamics in the Prognosis of Small Vessel Disease-associated, Cerebrovascular Events
Combined 3- and 7 Tesla-MRI - Intracerebral Hemorrhage, CAA - Cerebral Amyloid Angiopathy
UnknownInsel Gruppe AG, University Hospital Bern602022-07-012023-03-17
Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy
None, pure observational study - Cerebral Amyloid Angiopathy, Siderosis
CompletedCentre Hospitalier Universitaire de Nīmes1112022-06-012025-12-04
Coach Pilot Study: Assessing Cognitive Function and Related Small Vessel Disease Markers After Intracerebral Hemorrhage
Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage
TerminatedLeiden University Medical Center22022-04-032024-11-18
Safety and Efficacy of Remote Ischemic Conditioning on Cerebral Amyloid Angiopathy. (RIC-CAA)
Remote ischemic conditioning - Cerebral Amyloid Angiopathy
Not applicableUnknownCapital Medical University302022-01-202022-01-26
Enpowering Progression Risk of Cerebral Amyloid Angiopathy
Cerebral Amyloid Angiopathy, CAA - Cerebral Amyloid Angiopathy
CompletedFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta2002021-11-012026-03-27
Remote Ischemic Conditioning for Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage
Remote ischemic conditioning - Intracerebral Hemorrhage Lobar, Cerebral Amyloid Angiopathy
Not applicableUnknownCapital Medical University302021-02-242021-06-16
the Safety and Efficacy of Antiplatelet Therapy in Patients of CAA
Aspirin/Clopidogrel - Cerebral Amyloid Angiopathy
UnknownShenzhen Second People's Hospital432021-02-202021-02-08
Detailed Clinical and MRI Characteristics in Primary Non-traumatic Convexity Subarachnoid Haemorrhage Elderly Patients.
usual care - Cerebral Amyloid Angiopathy, Subarachnoid Hemorrhage
CompletedCentre Hospitalier Universitaire de Nīmes502021-02-012021-04-01

Showing 20 of 38. Sign in to see all of them.

Narrower conditions

Cerebral Hemorrhage (12)  ·  Stroke (6)  ·  Alzheimer Disease (5)  ·  Cerebral Amyloid Angiopathy, Familial (5)  ·  Intracranial Hemorrhages (3)  ·  CADASIL (2)  ·  Cerebral Small Vessel Diseases (2)  ·  Cognitive Dysfunction (2)  ·  Hemorrhage (2)  ·  Ischemic Stroke (2)  ·  Amyloid angiopathy (1)  ·  Dementia (1)  ·  Disease Progression (1)  ·  Hemorrhagic Stroke (1)

Broader conditions

Amyloidosis (38)  ·  Brain Diseases (38)  ·  Cardiovascular Diseases (38)  ·  Central Nervous System Diseases (38)  ·  Cerebral Arterial Diseases (38)  ·  Cerebrovascular Disorders (38)  ·  Intracranial Arterial Diseases (38)  ·  Metabolic Diseases (38)  ·  Nutritional and Metabolic Diseases (38)  ·  Proteostasis Deficiencies (38)  ·  Vascular Diseases (38)  ·  Nervous System Diseases (37)  ·  Pathologic Processes (18)  ·  Pathological Conditions, Signs and Symptoms (18)  ·  Hemorrhage (13)

Interventions

Aspirin (1)  ·  Clopidogrel (1)  ·  Colchicine (1)  ·  Diet, Mediterranean (1)  ·  Magnetic Resonance Imaging (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Minocycline (1)  ·  NC 758 (1)  ·  Olive Oil (1)  ·  Pharmaceutical Preparations (1)  ·  Positron-Emission Tomography (1)  ·  Ticagrelor (1)  ·  caficrestat (1)  ·  florbetapir (1)  ·  ponezumab (1)

Sponsors

Centre Hospitalier Universitaire de Nīmes (7)  ·  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (4)  ·  Leiden University Medical Center (3)  ·  National Taiwan University Hospital (3)  ·  Capital Medical University (2)  ·  Insel Gruppe AG, University Hospital Bern (2)  ·  University Hospital, Toulouse (2)  ·  Alnylam Pharmaceuticals (1)  ·  Amydis Inc. (1)  ·  Anna Olczak (1)  ·  Arctic Therapeutics (1)  ·  Auburn University (1)  ·  Beijing Tiantan Hospital (1)  ·  Bellus Health Inc. - a GSK company (1)  ·  Huashan Hospital (1)

Countries

France (10)  ·  China (5)  ·  Netherlands (5)  ·  United States (5)  ·  Italy (4)  ·  Canada (3)  ·  Switzerland (3)  ·  Taiwan (3)  ·  Germany (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Iceland (1)  ·  Poland (1)

Top investigators

David J Seiffge, Prof, MD (2)  ·  Amal Kaddoumi, PhD (1)  ·  Anna Olczak, PhD (1)  ·  Christian Opherk, MD (1)  ·  Dimitri Renard, MD (1)  ·  Dongsheng Fan, doctor (1)  ·  Ellis van Etten, MD, PhD (1)  ·  Frank Wollenweber, MD (1)  ·  Jennifer Linn, MD (1)  ·  Marco Duering, MD (1)  ·  Martin Dichgans, MD (1)

Results publications

PMID 28570698, PMID 31958082, PMID 32394598, PMID 34000646, PMID 35972776, PMID 36241843, PMID 36442282, PMID 36878206, PMID 37277877, PMID 37620982, PMID 38228908, PMID 38920025, PMID 40626372, PMID 40932118, PMID 41813043, PMID 42085649

NIH funding

2023 (2), 2015 (1), 2019 (1)